Stock Traders Purchase High Volume of Teladoc Health Call Options (NYSE:TDOC)

Key Points

• Teladoc Health saw a significant rise in options trading with stock traders purchasing 41,160 call options, an increase of about 52% compared to the normal volume.
• The company's stock price increased by 8.4% to reach $9.32, with over 5.5 million shares traded on Friday.
• Recent analyst ratings show a consensus of "Hold" for Teladoc Health, with price targets ranging from $9.00 to $10.50 from various analysts.

Teladoc Health, Inc. (NYSE:TDOC - Get Free Report) was the recipient of unusually large options trading on Friday. Stock traders purchased 41,160 call options on the company. This represents an increase of approximately 52% compared to the typical volume of 26,999 call options.

Teladoc Health Trading Up 8.4%

TDOC traded up $0.72 during trading on Friday, reaching $9.32. 5,597,027 shares of the stock traded hands, compared to its average volume of 6,946,522. The stock's 50-day moving average is $8.07 and its 200 day moving average is $7.65. Teladoc Health has a 12 month low of $6.35 and a 12 month high of $15.21. The stock has a market capitalization of $1.65 billion, a PE ratio of -7.83 and a beta of 1.90. The company has a quick ratio of 2.58, a current ratio of 2.67 and a debt-to-equity ratio of 0.70.

Teladoc Health (NYSE:TDOC - Get Free Report) last announced its quarterly earnings data on Tuesday, July 29th. The health services provider reported ($0.19) earnings per share for the quarter, beating the consensus estimate of ($0.27) by $0.08. Teladoc Health had a negative net margin of 8.16% and a negative return on equity of 10.13%. The firm had revenue of $631.90 million for the quarter, compared to analyst estimates of $621.91 million. During the same quarter in the prior year, the business earned ($0.38) earnings per share. The business's quarterly revenue was down 1.6% compared to the same quarter last year. Teladoc Health has set its Q3 2025 guidance at -0.350--0.200 EPS. FY 2025 guidance at -1.350--1.000 EPS. Equities analysts anticipate that Teladoc Health will post -1.16 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on TDOC shares. Mizuho initiated coverage on shares of Teladoc Health in a research note on Friday, July 25th. They issued a "neutral" rating and a $10.00 price objective on the stock. Citigroup boosted their target price on shares of Teladoc Health from $9.50 to $10.50 and gave the stock a "neutral" rating in a research note on Tuesday. Evercore ISI boosted their target price on shares of Teladoc Health from $8.00 to $9.00 and gave the stock an "in-line" rating in a research note on Wednesday, October 8th. Zacks Research raised shares of Teladoc Health from a "hold" rating to a "strong-buy" rating in a research note on Friday, October 10th. Finally, Weiss Ratings restated a "sell (d-)" rating on shares of Teladoc Health in a report on Wednesday, October 8th. One investment analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, eleven have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the company presently has a consensus rating of "Hold" and a consensus target price of $9.97.

Hedge Funds Weigh In On Teladoc Health

Several institutional investors have recently made changes to their positions in the stock. State of Alaska Department of Revenue acquired a new position in shares of Teladoc Health during the third quarter valued at about $75,000. KLP Kapitalforvaltning AS raised its holdings in shares of Teladoc Health by 23.2% in the 3rd quarter. KLP Kapitalforvaltning AS now owns 40,300 shares of the health services provider's stock worth $312,000 after acquiring an additional 7,600 shares during the last quarter. Capital Advisors Inc. OK raised its holdings in shares of Teladoc Health by 300.0% in the 3rd quarter. Capital Advisors Inc. OK now owns 80,000 shares of the health services provider's stock worth $618,000 after acquiring an additional 60,000 shares during the last quarter. Wealth Management Associates Inc. raised its holdings in shares of Teladoc Health by 15.5% in the 3rd quarter. Wealth Management Associates Inc. now owns 67,525 shares of the health services provider's stock worth $522,000 after acquiring an additional 9,075 shares during the last quarter. Finally, VIRGINIA RETIREMENT SYSTEMS ET Al raised its holdings in shares of Teladoc Health by 61.8% in the 3rd quarter. VIRGINIA RETIREMENT SYSTEMS ET Al now owns 150,075 shares of the health services provider's stock worth $1,160,000 after acquiring an additional 57,300 shares during the last quarter. Institutional investors and hedge funds own 76.82% of the company's stock.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.